Company

Odyssey Therapeutics, Inc.

Odyssey Therapeutics develops medicines for autoimmune diseases, inflammation, and cancer.

About

Founded in 2021 and based in Massachusetts, Odyssey Therapeutics develops therapeutics for autoimmune and inflammatory diseases and cancer, using machine-learning techniques. Its research includes immunomodulators and oncology medicines. In September 2025, it raised USD 213 million in Series D funding from Affinity Asset Advisors, Dimension Capital Management, Jeito Capital, Lightspeed Venture Partners, TPG, and Wedbush Securities, with other investors participating.

4Funding rounds

23Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in